Dementia risk does not differ with GLP-1 RAs, DPP4is for seniors with type 2 diabetes, study finds
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is), ...
Jul 22, 2025
0
0